SuperiorGroup of Companies Inc Dossier - Source-backed chat

SuperiorGroup of Companies Inc

SGCNASDAQ

SectorConsumer Discretionary

IndustryApparel, Accessories & Luxury Goods

Beta (adjusted)1.30

Intrinsic Value $15.75median of 6 methods · middle span $13-$20based on filings through 30 Jun 2026

Market Price $12.94Price as of 1 Oct 2026

UndervaluedIntrinsic value is 22% above the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $206.3M

Enterprise Value $265.5M

Shares Outstanding 14.7M diluted

Moat Rating None

Next Earnings Date2 Nov 2026

Last ex-dividend15 May 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Superior Group of Companies, Inc. (SGC) presents a balanced risk-reward profile as of mid-2026. The company is successfully executing its cost-control measures and portfolio optimization, which drove a significant bottom-line beat in Q1 2026 (EPS of $0.06 vs. $0.02 consensus). However, top-line growth remains modest (guided at 1-3% for FY 2026), and performance is highly mixed across segments. While the Branded Products segment (BAMKO) continues to stabilize and drive healthy cash flows, the Healthcare Apparel and Contact Centers segments face structural and macroeconomic headwinds. Trading near its fair value range of $13 to $16, the stock is a classic 'Hold' for income-focused investors seeking a stable ~4% dividend yield, but lacks immediate catalysts for significant multiple expansion.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets3 analysts · as of 18 Aug 2026

Low · most bearish analyst$15.00

Mean target$17.00

High · most bullish analyst$20.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$11.0015%

The bear case is triggered by prolonged weakness and customer downsizing in the Contact Centers segment, combined with intensified competitive pressure in Healthcare Apparel from premium DTC players like FIGS. If corporate discretionary spending on branded merchandise softens due to broader macroeconomic headwinds, SGC's top-line growth could turn negative, dragging EPS down to the lower end of guidance ($0.54) or below, leading to multiple contraction.

Base CaseCentral scenario

$15.0060%

The base case assumes SGC performs in line with management's FY 2026 guidance, delivering net sales of $572 million to $585 million (representing ~2.2% growth at the midpoint) and diluted EPS of $0.54 to $0.66. The company maintains its quarterly dividend of $0.14 per share, supported by steady free cash flow generation and a stable net debt-to-EBITDA leverage ratio of approximately 2.0x. Valuation multiples remain stable, reflecting SGC's mature business profile and balanced segment performance.

Bull CaseUpside scenario

$16.0025%

The bull case is driven by faster-than-expected margin expansion in the Branded Products segment and a strong cyclical rebound in corporate promotional spending. Additionally, if the high-margin Contact Centers segment (The Office Gurus) accelerates its nearshore BPO market share gains while maintaining EBITDA margins above 20%, consolidated profitability will exceed the top end of guidance. Under this scenario, SGC achieves the high end of its FY 2026 EPS guidance ($0.66) and positions itself for a stronger growth trajectory in FY 2027.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Diversified business model across three distinct segments (Healthcare Apparel, Branded Products, Contact Centers) balances cyclicality.
Strong history of capital return with uninterrupted annual dividend payments since 1977.
Successful deleveraging efforts, reducing net debt-to-EBITDA to a healthy ~2.0x level.
Outsized profitability and high margins (>20% EBITDA) in the nearshore Contact Centers segment.

Key Investment Risks

Discretionary nature of corporate spending on branded merchandise and promotional products.
Intense competition in the healthcare uniform space from direct-to-consumer disruptors like FIGS.
Exposure to nearshore labor availability and wage inflation in BPO operating regions.
Low single-digit organic top-line growth limits near-term valuation upside.

Thesis Invalidation Triggers

Consolidated net sales for FY 2026 falling below the guided floor of $572 million.
A significant drop in Contact Centers EBITDA margins below 18% due to labor cost escalation.
A decision by the Board to reduce or suspend the quarterly dividend.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.